| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/STROKEAHA.112.659409 |
| P698 | PubMed publication ID | 22764211 |
| P50 | author | Francisco Moniche | Q42350448 |
| Aurelio Cayuela | Q43276871 | ||
| Joan Montaner | Q60879344 | ||
| P2093 | author name string | Anna Rosell | |
| Ildefonso Espigado | |||
| Alejandro Gonzalez | |||
| Magdalena Carmona | |||
| Pilar Piñero | |||
| Maria-Dolores Jimenez | |||
| Alberto Gil-Peralta | |||
| Antonio Mayol | |||
| Cristina Boada | |||
| Jose-Ramon Gonzalez-Marcos | |||
| David Garcia-Solis | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2242-2244 | |
| P577 | publication date | 2012-07-03 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial | |
| P478 | volume | 43 |
| Q90599623 | Activated Mesenchymal Stem Cells Induce Recovery Following Stroke Via Regulation of Inflammation and Oligodendrogenesis |
| Q90290287 | Adult Stem Cells and Induced Pluripotent Stem Cells for Stroke Treatment |
| Q64880151 | Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety Study. |
| Q34107076 | An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside |
| Q38264294 | Application of microRNAs in diagnosis and treatment of cardiovascular disease |
| Q37604725 | Autologous Stem Cell Transplantation Promotes Mechanical Stretch Induced Skin Regeneration: A Randomized Phase I/II Clinical Trial |
| Q46265702 | Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. |
| Q36112236 | Bone marrow mononuclear cell therapy in ischaemic stroke: a systematic review |
| Q38210965 | Bone marrow stromal cells as a therapeutic treatment for ischemic stroke |
| Q27025754 | Cell based therapies for ischemic stroke: from basic science to bedside |
| Q43099109 | Cell therapy demonstrates promise for acute respiratory distress syndrome - but which cell is best? |
| Q91782020 | Cell-Based Therapies for Stroke: Are We There Yet? |
| Q39554131 | Challenges enrolling patients with acute ischemic stroke into cell therapy trials |
| Q26851906 | Clinical imaging in regenerative medicine |
| Q48100040 | Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke. |
| Q38079789 | Concise review: Preclinical studies on human cell-based therapy in rodent ischemic stroke models: where are we now after a decade? |
| Q48015434 | Controlled clinical trials of cell therapy in stroke: Meta-analysis at six months after treatment |
| Q37049533 | Cryopreservation of Bone Marrow Mononuclear Cells Alters Their Viability and Subpopulation Composition but Not Their Treatment Effects in a Rodent Stroke Model |
| Q28087451 | Developing Cellular Therapies for Stroke |
| Q40429078 | Developing drug strategies for the neuroprotective treatment of acute ischemic stroke. |
| Q55239568 | Diabetic Ephrin-B2-Stimulated Peripheral Blood Mononuclear Cells Enhance Poststroke Recovery in Mice. |
| Q35910972 | Effectiveness and Safety of Autologous Bone Marrow Stromal Cells Transplantation After Ischemic Stroke: A Meta-Analysis |
| Q38738192 | Effects of human umbilical cord blood mononuclear cells on respiratory system mechanics in a murine model of neonatal lung injury |
| Q34599756 | Efficacy and safety of stem cell therapies for patients with stroke: a systematic review and single arm meta-analysis |
| Q92417898 | Efficacy of stem cell-based therapies for stroke |
| Q33705402 | Endothelial progenitor cells: therapeutic perspective for ischemic stroke |
| Q34984321 | Factors secreted by endothelial progenitor cells enhance neurorepair responses after cerebral ischemia in mice |
| Q36685619 | History of Neural Stem Cell Research and Its Clinical Application |
| Q50655307 | How to unfasten the Spanish Stroke Belt? Andalusia chooses research. |
| Q26797993 | Immune interventions in stroke |
| Q64325140 | Immunological and non-immunological effects of stem cell-derived extracellular vesicles on the ischaemic brain |
| Q37150563 | Increasing Dose of Autologous Bone Marrow Mononuclear Cells Transplantation Is Related to Stroke Outcome: Results from a Pooled Analysis of Two Clinical Trials |
| Q37474699 | Inflammatory Disequilibrium in Stroke |
| Q34428957 | Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke |
| Q35663793 | Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms |
| Q37507497 | Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Stem Cells in Subacute Ischemic Stroke Patients |
| Q53082672 | Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial. |
| Q48144302 | Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose-finding, controlled multicenter trial |
| Q42152041 | Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. |
| Q36092131 | Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients |
| Q48331191 | Intravenously Transplanted Human Bone Marrow Endothelial Progenitor Cells Engraft Within Brain Capillaries, Preserve Mitochondrial Morphology, and Display Pinocytotic Activity Toward Blood-Brain Barrier Repair in Ischemic Stroke Rats |
| Q92650424 | Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application |
| Q61771939 | Mobilization of endothelial progenitor cells in acute cardiovascular events in the PROCELL study: Time-course after acute myocardial infarction and stroke |
| Q64975178 | Modern Concepts in Regenerative Therapy for Ischemic Stroke: From Stem Cells for Promoting Angiogenesis to 3D-Bioprinted Scaffolds Customized via Carotid Shear Stress Analysis. |
| Q33789162 | Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone. |
| Q33772112 | Neural repair and neuroprotection with stem cells in ischemic stroke |
| Q90081477 | Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles |
| Q37028288 | Neurorestoration after stroke. |
| Q33813333 | Neurorestorative therapy for stroke |
| Q26800178 | Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology and Its Impact on Clinical Treatments |
| Q88405456 | Pharmacological approaches promoting stem cell-based therapy following ischemic stroke insults |
| Q41608195 | Phase I/II randomized controlled trial of autologous bone marrow-derived mesenchymal stem cell therapy for chronic stroke. |
| Q38675024 | Promoting recovery from ischemic stroke |
| Q64076879 | Promoting therapeutic angiogenesis of focal cerebral ischemia using thrombospondin-4 (TSP4) gene-modified bone marrow stromal cells (BMSCs) in a rat model |
| Q52653365 | Randomized Assessment of the Safety and Efficacy of Intra-Arterial Infusion of Autologous Stem Cells in Subacute Ischemic Stroke. |
| Q39154453 | Regenerative capacity of autologous stem cell transplantation in elderly: a report of biomedical outcomes |
| Q34340851 | Robotics, stem cells, and brain-computer interfaces in rehabilitation and recovery from stroke: updates and advances |
| Q38543812 | Role of exosomes and microvesicles in hypoxia-associated tumour development and cardiovascular disease. |
| Q38601839 | Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysis |
| Q54015446 | Stem Cell Therapy and Administration Routes After Stroke. |
| Q34442610 | Stem cell therapies in preclinical models of stroke associated with aging |
| Q26866149 | Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? |
| Q46950469 | Stem cell therapy in stroke treatment: is it a viable option? |
| Q91765784 | Stem cell transplantation for ischemic stroke |
| Q37238494 | Stem cell transplantation for neuroprotection in stroke. |
| Q34391064 | Stem cell transplantation in neurological diseases: improving effectiveness in animal models |
| Q34419548 | Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability |
| Q38268307 | Strategies for early stroke recovery: what lies ahead? |
| Q30387946 | Systematic Review and Meta-Analysis of Bone Marrow-Derived Mononuclear Cells in Animal Models of Ischemic Stroke |
| Q38888000 | TOOTH (The Open study Of dental pulp stem cell Therapy in Humans): Study protocol for evaluating safety and feasibility of autologous human adult dental pulp stem cell therapy in patients with chronic disability after stroke |
| Q26800181 | The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke |
| Q38835646 | The Dose of Intravenously Transplanted Bone Marrow Stromal Cells Determines the Therapeutic Effect on Vascular Remodeling in a Rat Model of Ischemic Stroke |
| Q57478906 | The convergence of regenerative medicine and rehabilitation: federal perspectives |
| Q41089568 | The long-term fate of mesenchymal stem cells labeled with magnetic resonance imaging-visible polymersomes in cerebral ischemia. |
| Q36318376 | The potential benefit of stem cell therapy after stroke: an update |
| Q37025630 | The rise of cell therapy trials for stroke: review of published and registered studies |
| Q38099747 | Therapeutic applications of bone marrow-derived stem cells in ischemic stroke |
| Q48748310 | Transplantation of hematopoietic stem cells: intra-arterial versus intravenous administration impacts stroke outcomes in a murine model |
Search more.